Drug intelligence / Profile preview

[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine

Development stage
Unknown
Modality
Small Molecules
01

Overview

[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine is a synthetic small molecule belonging to the class of benzene and substituted derivatives. It features a benzamidine core with a dioxaborolane substituent. The compound is primarily used as an experimental tool in biochemical research and has been identified as a potential inhibitor of serine proteases such as trypsin. Its mechanism involves mimicking the transition state or binding at the active site of target enzymes to inhibit their activity. There are no approved therapeutic indications for this compound; it is mainly utilized in laboratory settings for enzyme inhibition studies and structure-based drug design[1][3][7].

Other names
(4-(1,3,2-dioxaborolan-2-yloxy)methyl)benzamidine(amino((4-((1,3,2-dioxaborolan-2-yloxy)methyl)phenyl))methylidene)azanium[amino({4-[(1,3,2-dioxaborolan-2-yloxy)methyl]phenyl})methylidene]azanium
02

Targets

PRSS3 (Trypsin-3)

Beyond the preview

Go deeper on [4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call